trimethyoprim-sulfamethoxazole
- synergistic drug combination;
- inhibits pathway important in synthesis of purine nucleotide resulting in inhibition of DNA synthesis;
- commonly used to treat UTIs and CA-MRSA skin and soft tissue infections;
- active against pneumocystis and selected parasites;
- developed in RTP